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p38α, a non-receptor serine/threonine kinase, plays an essential role in cell 
proliferation, cell differentiation, apoptosis, production of cytokines such as 
IL1β and TNFα, senescence and tumorigenesis. 
Over expression of p38α enhances the production of cytokines, leading to in-
flammation causing cancers. Therefore, the protein p38α selected as a target 
for the inhibition of progression of inflammatory cancers. 
Inhibitory drug molecules of human p38α reported till date are in preclinical 
stages. In these clinical studies, the drug molecules had shown side effects 
such as liver toxicity, development of lung tumors particularly in smokers. 
 Virtual screening and docking techniques were utilized herein to gain insight 
on identifying a new potential inhibitors. 
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Figure 2.T he crystal structure of  p38α  (ID 3HVC) 
along with inhibitor GG5. The active site residues 
are   Val30, Ser32, Val38,  Ala51, Val52, Lys53, 
Leu75, Ile84, Gly85, Leu86, Leu104, Thr106, 
His107, Leu108, Met109, Val110, Leu167 and  
Asp168  
Figure1. Rooted tree was constructed by 
using the FITCH algorithm of Neighbor- 
joining method. p38γ and p38δ were 
closely related to p38α and is distantly 
related to eukaryotic elongation factor 2 
kinase 
In comparison with the nine existing inhibitors, lead ‘1’ (N-(3-Benzooxazol-
2-yl-4-hydroxy-phenyl) 2ptolyloxyacetamide) has lowest binding affinity 
among the lead molecules with XP Gscore of -9.38 kcal/mol and forming 
four hydrogen bonds: one with each of Ala 51, Glu71 and Asp168 and one 
water bond (position 420) with a well complementing binding mode with 
the crystallographic data of human p38α. Therefore, Lead ’1’ can be raised 
into potential inhibitors after binding assays and passing several phases of 
clinical trials. 
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Figure 4 Docking complex of p38α and Lead’1’molecule 
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